Sanofi is pooling digital resources, know-how and capital in a new joint venture to drive healthcare solutions. The French pharma is joining tech firm Capgemini, ins...

Once again, GlaxoSmithKline has topped pharma company medicine accessibility rankings in a biennial global report, out Tuesday. Compiled by the Access to Medicine Fou...

Pfizer and Moderna have agreed to deliver another 200 million COVID-19 vaccine doses to the U.S., bringing the total on tap to 600 million, or enough to vaccinate 300...

As the demand for COVID-19 vaccines from Moderna, Pfizer and AstraZeneca continues to outstrip supply and alternative vaccines struggle to make it out of the pipeline...

Fresenius Kabi's manufacturing hiccups multiplied as 2020 unfolded. Now, a little more than a week into the new year, the German drugmaker found its way onto the FDA'...

Bayer and partner Merck & Co. have carried a new heart failure drug across the FDA finish line, hoping to carve blockbuster share out of an ever-more-competitive ...

The Nasdaq Biotechnology Index has risen more than 600% in the last 15 years, reflecting investor enthusiasm for a flood of novel drugs that Wall Street analysts pegg...

Politicians of all stripes have run on promises to lower drug prices over the years, and outgoing President Donald Trump was no different. Fast-forward four years—pas...

As more supplies of Pfizer-BioNTech and Moderna’s authorized COVID-19 vaccines arrive, many states are expanding their reach beyond the elderly and into the 65-plus c...

Just hours after U.S. President Joe Biden was inaugurated, Janet Woodcock officially took the reins at the FDA. She will service as acting commissioner in an anticipa...